Scleroderma therapy：a review of recent advances and perspective
CHEN Wei
YANG Rong-ya
Abstract：Scleroderma (systemic sclerosis, SSc) is a chronic, multisystem connective tissue disease with a complex pathogenesis. Till now there is no sole therapy with optimal beneficial effects on all aspects of the disease process. It usually requires interdisciplinary approach in individual patient management. Recently, Clinical research to unravel the pathogenesis of scleroderma has implicated multiple cellular and molecular factors that are potential targets for future therapy. The objective of this article is to provide an overview of the available treatments and recent advances in the therapy of Scleroderma. These therapies have been classified into categories according to their mode of action-immunomodulators, antifibrotic or vasodilators and each will be discussed individually.
Keywords：SclerodermaTherapy
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 367-370 )